Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk.


Journal

Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 10 04 2018
revised: 02 08 2018
accepted: 07 09 2018
pubmed: 30 11 2018
medline: 12 3 2020
entrez: 30 11 2018
Statut: ppublish

Résumé

There remains debate about whether risk-reducing salpingo-oophorectomy (RRSO), which reduces ovarian cancer risk, also reduces breast cancer risk. We examined the association between RRSO and breast cancer risk using a prospective cohort of 17 917 women unaffected with breast cancer at baseline (7.2% known carriers of BRCA1 or BRCA2 mutations). During a median follow-up of 10.7 years, 1046 women were diagnosed with incident breast cancer. Modeling RRSO as a time-varying exposure, there was no association with breast cancer risk overall (hazard ratio [HR] = 1.04, 95% confidence interval [CI] = 0.87 to 1.24) or by tertiles of predicted absolute risk based on family history (HR = 0.68, 95% CI = 0.32 to 1.47, HR = 0.94, 95% CI = 0.70 to 1.26, and HR = 1.10, 95% CI = 0.88 to 1.39, for lowest, middle, and highest tertile of risk, respectively) or for BRCA1 and BRCA2 mutation carriers when examined separately. There was also no association after accounting for hormone therapy use after RRSO. These findings suggest that RRSO should not be considered efficacious for reducing breast cancer risk.

Identifiants

pubmed: 30496449
pii: 5212812
doi: 10.1093/jnci/djy182
pmc: PMC6410936
doi:

Substances chimiques

BRCA1 Protein 0
BRCA1 protein, human 0
BRCA2 Protein 0
BRCA2 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-334

Subventions

Organisme : NCI NIH HHS
ID : T32 CA094061
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001875
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164920
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press.

Références

Hum Mutat. 2002 Jul;20(1):65-73
pubmed: 12112659
Breast Cancer Res. 2004;6(4):R375-89
pubmed: 15217505
Br J Cancer. 2004 Oct 18;91(8):1580-90
pubmed: 15381934
J Clin Oncol. 2005 Oct 20;23(30):7491-6
pubmed: 16234515
J Natl Compr Canc Netw. 2006 Feb;4(2):177-82
pubmed: 16451773
J Clin Oncol. 2008 Mar 10;26(8):1331-7
pubmed: 18268356
Breast Cancer Res Treat. 2009 Jul;116(2):379-86
pubmed: 18704680
JAMA. 2010 Sep 1;304(9):967-75
pubmed: 20810374
J Natl Cancer Inst. 2015 Mar 18;107(5):null
pubmed: 25788320
Int J Epidemiol. 2016 Jun;45(3):683-92
pubmed: 26174520
J Natl Cancer Inst. 2016 Sep 06;109(1):
pubmed: 27601060
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866

Auteurs

Mary Beth Terry (MB)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.

Mary B Daly (MB)

Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA.

Kelly Anne Phillips (KA)

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Xinran Ma (X)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.

Nur Zeinomar (N)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.

Nicole Leoce (N)

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.

Gillian S Dite (GS)

Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.

Robert J MacInnis (RJ)

Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.
Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.

Wendy K Chung (WK)

Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
Departments of Pediatrics and Medicine, Columbia University, New York, NY.

Julia A Knight (JA)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Melissa C Southey (MC)

Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.

Roger L Milne (RL)

Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.
Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.

David Goldgar (D)

Department of Medicine and Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT.

Graham G Giles (GG)

Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.

Prue C Weideman (PC)

Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.
The Research Department, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Gord Glendon (G)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.

Richard Buchsbaum (R)

Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY.

Irene L Andrulis (IL)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Esther M John (EM)

Department of Medicine and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.

Saundra S Buys (SS)

Department of Medicine and Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT.

John L Hopper (JL)

Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH